# Auris Medical Holding Ltd. (EARS) Source: https://www.quantisnow.com/company/EARS Generated: 2026-11-12T11:55:31.924Z - Ticker: EARS - Exchange: NASDAQ - Sector: Health Care - Industry: Major Pharmaceuticals - IPO year: 2014 ## Latest EARS news and filings - 2021-09-08 13:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-1749934) - 2021-07-23 20:09 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-1480712) - 2021-07-14 13:00 UTC [Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2](https://www.quantisnow.com/insight/auris-medical-announces-publication-of-data-from-preclinical-studies-with-1359515) - 2021-07-06 13:00 UTC [Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology](https://www.quantisnow.com/insight/auris-medical-to-develop-kras-targeting-rna-treatment-for-colorectal-cancer-1259096) - 2021-06-28 12:30 UTC [Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany](https://www.quantisnow.com/insight/auris-medical-to-initiate-market-launch-of-bentrio-nasal-spray-1164714) - 2021-06-21 12:30 UTC [Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma](https://www.quantisnow.com/insight/auris-medical-announces-significant-inhibition-of-tumor-growth-with-oligophore-1080411) - 2021-06-16 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-1031325) - 2021-06-08 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-auris-medical-holding-ltd-969502) - 2021-06-03 11:36 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-951094) - 2021-06-03 11:30 UTC [Conference Announcement] [Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning](https://www.quantisnow.com/insight/auris-medical-announces-acquisition-of-rna-therapeutics-company-and-plans-950982) - 2021-06-02 20:16 UTC [SEC Form POS AM filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-auris-medical-holding-ltd-942892) - 2021-06-02 13:25 UTC [SEC Form POS AM filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-auris-medical-holding-ltd-935341) - 2021-06-01 12:30 UTC [Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India](https://www.quantisnow.com/insight/auris-medical-starts-preparations-for-covid-19-trial-with-bentrio-in-915672) - 2021-05-28 12:30 UTC [Conference Announcement] [Auris Medical Holding to Present at LD Micro Invitational XI Conference](https://www.quantisnow.com/insight/auris-medical-holding-to-present-at-ld-micro-invitational-xi-890339) - 2021-05-25 13:00 UTC [Auris Medical Announces Completion of Bentrio Conformity Assessment Procedure for Marketing in EU](https://www.quantisnow.com/insight/auris-medical-announces-completion-of-bentrio-conformity-assessment-procedure-for-835550) - 2021-05-21 11:31 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Auris Medical Holding Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-auris-medical-holding-ltd-798344) - 2021-05-17 12:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-748516) - 2021-05-14 12:30 UTC [Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo](https://www.quantisnow.com/insight/auris-medical-reaches-midpoint-for-enrollment-in-part-b-of-742723) - 2021-05-07 13:05 UTC [Auris Medical Provides Update on Bentrio Program in Allergy](https://www.quantisnow.com/insight/auris-medical-provides-update-on-bentrio-program-in-allergy-715556) - 2021-04-16 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-625574) - 2021-04-13 11:45 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-610854) - 2021-04-13 11:45 UTC [Conference Announcement] [Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch](https://www.quantisnow.com/insight/auris-medical-announces-positive-preclinical-and-clinical-outcomes-with-am-301-610838) - 2021-03-31 12:30 UTC [Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results ](https://www.quantisnow.com/insight/auris-medical-provides-business-update-and-reports-second-half-and-570697) - 2021-03-31 12:27 UTC [SEC Form 6-K] [SEC Form 6-K filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-auris-medical-holding-ltd-570633) - 2021-03-31 12:00 UTC [SEC Form 20-F filed by Auris Medical Holding Ltd.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-auris-medical-holding-ltd-570424) - 2021-03-24 12:00 UTC [Conference Announcement] [Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, 2021 Auris Medical AG](https://www.quantisnow.com/insight/auris-medical-to-report-second-half-and-full-year-2020-547198) - 2021-03-12 13:56 UTC [SEC Form 6-K filed](https://www.quantisnow.com/insight/sec-form-6-k-filed-505392) - 2021-02-12 22:15 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-392604) - 2021-01-29 13:30 UTC [Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis ](https://www.quantisnow.com/insight/auris-medical-announces-initiation-of-clinical-investigation-of-am-301-in-329024) - 2021-01-15 21:38 UTC [SEC Form 6-K filed](https://www.quantisnow.com/insight/sec-form-6-k-filed-289357) - 2021-01-15 21:32 UTC [SEC Form 424B5 filed](https://www.quantisnow.com/insight/sec-form-424b5-filed-289316) - 2021-01-15 21:05 UTC [SEC Form S-8 filed](https://www.quantisnow.com/insight/sec-form-s-8-filed-289081) - 2020-12-15 13:30 UTC [Public Offering] [Auris Medical Provides Business Update ](https://www.quantisnow.com/insight/auris-medical-provides-business-update-217051) - 2020-12-07 21:10 UTC [Conference Announcement] [Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference ](https://www.quantisnow.com/insight/auris-medical-holding-to-present-at-the-13th-annual-ld-201939) - 2020-12-02 13:45 UTC [Public Offering] [Auris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-Market](https://www.quantisnow.com/insight/auris-medical-holding-ltd-prices-8000000-common-shares-offering-priced-193343) - 2020-12-01 14:00 UTC [Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection ](https://www.quantisnow.com/insight/auris-medical-reports-positive-in-vitro-efficacy-data-for-am-301-190462) - 2020-11-20 14:10 UTC [Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica ](https://www.quantisnow.com/insight/auris-medical-launches-website-for-am-301-focused-subsidiary-altamira-medica-172453) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EARS - Earnings history: https://www.quantisnow.com/earnings/EARS - Dividend history: https://www.quantisnow.com/dividends/EARS - Insider transactions: https://www.quantisnow.com/insiders/EARS - Options chain: https://www.quantisnow.com/options/EARS - SEC 8-K filings only: https://www.quantisnow.com/company/EARS/8-k - RSS and alerts for EARS: https://www.quantisnow.com/docs/rss-feeds.md